Novel Alzheimer's Pill May Slow Decline in Some High-Risk Patients

(MedPage Today) — A Phase III trial of investigational valiltramiprosate (ALZ-801) failed to meet its primary endpoint in people with early symptoms of Alzheimer’s disease, but the drug showed benefit in a predefined population with mild cognitive impairment…